Evidence map›Paper›PMID 33775979›Full record

ArticleJournal of atherosclerosis and thrombosis2022

Group V Secretory Phospholipase A

Daisuke Fujioka, Yosuke Watanabe, Takamitsu Nakamura, Takashi Yokoyama, Keiji Miyazawa, Makoto Murakami, Kiyotaka Kugiyama

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daisuke FujiokaDepartment of Internal Medicine II, University of Yamanashi, Faculty of Medicine.
Yosuke WatanabeDepartment of Internal Medicine II, University of Yamanashi, Faculty of Medicine.
Takamitsu NakamuraDepartment of Internal Medicine II, University of Yamanashi, Faculty of Medicine.
Takashi YokoyamaDepartment of Biochemistry, University of Yamanashi, Faculty of Medicine.
Keiji MiyazawaDepartment of Biochemistry, University of Yamanashi, Faculty of Medicine.
Makoto MurakamiLaboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, University of Tokyo.
Kiyotaka KugiyamaDepartment of Internal Medicine II, University of Yamanashi, Faculty of Medicine.
University of Yamanashi · JPJapan Agency for Medical Research and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIt was suggested that group V secretory phospholipase A

methodsRAW264.7 cells were transfected with shRNA vector targeting sPLA

resultsIn immunofluorescence microscopic studies, sPLA

conclusionsNuclear sPLA

Indexed as

ActinsPhospholipases A2, SecretoryBeclin-1Cell LineEndocytosisHumansLipoproteins, LDLMacrophagesPhosphoglycerate KinaseTranscriptional Activationacetyl-LDLActinsBeclin-1Lipoproteins, LDLPGK1 protein, humanPhosphoglycerate KinasePhospholipases A2, SecretoryActin polymerizationEndocytosisGroup V secretory phospholipase A2MacrophagePhosphoglycerate kinase 1

Identifiers

PMID33775979
PMCPMC9135649
OpenAlexW3151001826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.